CTRI/2024/10/075188 [Registered on: 14/10/2024] Trial Registered Prospectively
Last Modified On:
04/10/2024
Post Graduate Thesis
Yes
Type of Trial
Interventional
Type of Study
Ayurveda
Study Design
Single Arm Study
Public Title of Study
Exploring the effectiveness of combined Ayurvedic treatment protocol for the management of Pushpaghni Jataharini (Polycystic Ovary Syndrome)
Scientific Title of Study
Evaluation of the clinical efficacy of multimodal Ayurvedic treatment protocol in the management of Pushpaghni Jataharini (Polycystic Ovary Syndrome): An Exploratory Study
Trial Acronym
Nil
Secondary IDs if Any
Secondary ID
Identifier
NIL
NIL
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
Name
Dr Veena Lalwani
Designation
PG Scholar
Affiliation
All India Institute of Ayurveda
Address
7th Floor, Room No 725, Department of Panchakarma, Academic Block, All India Institute of Ayurveda, Gautampuri, Sarita Vihar, Delhi South
South DELHI 110076 India
Phone
9584751297
Fax
Email
veenalalwani011@gmail.com
Details of Contact Person Scientific Query
Name
Dr Santosh Kumar Bhatted
Designation
Professor
Affiliation
All India Institute of Ayurveda
Address
Room no. 703, Department of Panchakarma, Academic Block, All India Institute of Ayurveda, Gautampuri, Sarita Vihar, Delhi South
South DELHI 110076 India
Phone
9414048459
Fax
Email
santoshbhatted@rediffmail.com
Details of Contact Person Public Query
Name
Dr Santosh Kumar Bhatted
Designation
Professor
Affiliation
All India Institute of Ayurveda
Address
Room no. 703, Department of Panchakarma, Academic Block, All India Institute of Ayurveda, Gautampuri, Sarita Vihar, Delhi South
South DELHI 110076 India
Phone
9414048459
Fax
Email
santoshbhatted@rediffmail.com
Source of Monetary or Material Support
All India Institute of Ayurveda,Gautampuri Awas, Sarita Vihar,Delhi South, 110076,India
Primary Sponsor
Name
All India Institute of Ayurveda
Address
7th Floor, Department of Panchakarma, Academic Block, All India Institute of Ayurveda,Gautampuri Awas,Sarita Vihar,Delhi 110076,India
Type of Sponsor
Research institution and hospital
Details of Secondary Sponsor
Name
Address
NIL
NIL
Countries of Recruitment
India
Sites of Study
No of Sites = 1
Name of Principal
Investigator
Name of Site
Site Address
Phone/Fax/Email
Dr Veena Lalwani
All India Institute of Ayurveda
OPD No. 6, Department of Panchakarma, Gautampuri Awas, Sarita Vihar, Delhi South,110076, India South DELHI
9584751297
veenalalwani011@gmail.com
Details of Ethics Committee
No of Ethics Committees= 1
Name of Committee
Approval Status
Division of Translational Research and Biostatistics, All India Institute of Ayurveda, Delhi South, 110076
(Procedure Reference: Kashyap samhita sidhi sthana chapter 7, Procedure details: It will be given in morning time between 9am -12 pm after taking some food on 1,3,5,7,8 th day of yoga basti.) (1) Medicine Name: Vidangadi taila anuvasana basti, Reference: Sushrut samhita chikitsa sthan chapter 37 verse 39-42, Route: Rectal, Dosage Form: Taila, Dose: 60(ml), Frequency: od, Duration: 5 Days
(Procedure Reference: Charak sidhi chapter 1 verse 38-41, Procedure details: It will be given in morning time between 8am -11 am, empty stomach on 2,4,6 th day of yoga basti.) (1) Medicine Name: Bhadradi Kwath niruha basti, Reference: sushrut samhita chikitsa sthana chapter 38 verse 60-63, Route: Rectal, Dosage Form: Kwatha/Kashaya, Dose: 420(ml), Frequency: od, Duration: 3 Days
(Procedure Reference: Charak sidhi chapter 2 verse 22, Procedure details: It will be given after 15 days of rest period after yoga basti.) (1) Medicine Name: Kalyanak ghrita , Reference: Charak sidhi chapter 9 verse 35-41, Route: Nasal, Dosage Form: Ghrita, Dose: 2(ml), Frequency: od, Duration: 7 Days
1.Reproductive Age Group: 16-40 years (both married/unmarried).
2.Patients with clinical features of PCOS like-
• Amenorrhea or Oligomenorrhoea
• Infertility
• Anovulation
• Acne
• Hirsutism
• Acanthosis nigricans
3. Along with confirmed any one Polycystic Ovary in USG finding.
4. Patients fit for Basti and Nasya karma.
5. ICD - 11 Code: 5A80.1 Polycystic ovary syndrome
ExclusionCriteria
Details
1. Primary amenorrhoea.
2. Pregnancy
3. Pelvic diseases like (Endometriosis, Hydrosalphinx, Fibroid uterus etc) causing Oligomenorrhoea and Anovulation.
4. Organic lesions of reproductive tract like T.B, Carcinoma and congenital deformities.
5. Hyperprolactenemia due to Pituitary Adenoma.
6. Cushing’s syndrome
Method of Generating Random Sequence
Not Applicable
Method of Concealment
Not Applicable
Blinding/Masking
Open Label
Primary Outcome
Outcome
TimePoints
To evaluate the effect of Ayurvedic treatment protocol on –
1.Polycystic ovaries in USG findings (in unmarried).
2.Follicular growth and ovulation (in married).
0th day and 64th day (after shaman chikitsa)
Secondary Outcome
Outcome
TimePoints
Relief in menstrual irregularities.
• Recovery of the Acne, Hirsutism, Acanthosis nigricans, BMI, Weight reduction.
• Improvement in quality of the life using PCOS QOL scale.
0th day, 34th day, 64th day, 94th day
Target Sample Size
Total Sample Size="20" Sample Size from India="20" Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials" Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials"
Phase of Trial
Phase 2
Date of First Enrollment (India)
01/03/2025
Date of Study Completion (India)
Applicable only for Completed/Terminated trials
Date of First Enrollment (Global)
Date Missing
Date of Study Completion (Global)
Applicable only for Completed/Terminated trials
Estimated Duration of Trial
Years="1" Months="0" Days="0"
Recruitment Status of Trial (Global)
Not Applicable
Recruitment Status of Trial (India)
Not Yet Recruiting
Publication Details
N/A
Individual Participant Data (IPD) Sharing Statement
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
Brief Summary
RESEARCHQUESTION :
What is the effect of Multi-modal Ayurvedic Treatment
Protocol in the management of Polycystic Ovary Syndrome (PCOS)?
There is significant
effect of Multi-modal Ayurvedic Treatment Protocol (Udvartana with Kolakulathadi
Churna, Sarvang Bashpa Swedana with Dashmool Kwatha and Pachana
with Vaishvanar Churna, followed by Koshta Shudhi with
Gandharvhasta Taila followed by Yoga Basti with Bhadradi Kwathand Vidangadi taila followed by Nasya
with Kalyanaka Ghrita followed by Shamana Chikitsa with Hingvashtak
Churna and Dashmool Kwath) in the management of Pushpaghni Jataharini(Polycystic
Ovary Syndrome).
NEED OF THE STUDY
1.Polycystic
ovarian syndrome is a most prevalent endocrinopathy. Now a days because of
sedentary lifestyles, incidence of this disease is very high. High prevalence
not only among reproductive age, but also among adolescents.
2.Patients
with PCOS are at risk of developing Hypertension, Diabetes mellitus, obesity,
anovulation and Infertility, Endometrial carcinoma, cardiovascular disease. 20%
of women with PCOS develops non-insulin dependent diabetes mallitus (NIDDM) by
the age of 30 years11.
3.No
permanent treatment is found for PCOS in modern therapy. The treatment given is
symptomatic and duration remains for a longer period. The treatment module
includes oral contraceptive, hormonal supplementation, ovulation induction
drugs, antiestrogenic etc., which given for long term can produce severe ill
effects on the body. Surgical drilling is one of the treatments given, but even
its effect is also temporary.
4.Application of Ayurvedic principles on the pathology
involved, reveal a distinct vitiation of Vata. As it is the
motive force behind the function of elimination or retention of mala, mutra,
artava. Vata can be
possibly normalized using the gold standard of Vata treatment – the ‘Basti
Chikitsa’.Nasya (intranasal drug therapy) is known to be highly
efficient on the central nervous system and regulate the H-P-O Axis, which is
dysregulated in PCOS.
5.Many clinical studies have been conducted to evaluate
the efficacy of various aspects of Ayurvedic drugs and panchakarma procedures
in the management of PCOS. But hardly an attempt is made for making an
effective Ayurvedic Treatment Protocol that is both effective and safe in the
management of PCOS. Thus making this study a novel. Hence the proposed study
has been planned to establish a fix standard Ayurvedic treatment protocol.
6.Due
to limitation of medical therapy as well as surgical interventions, it becomes
the necessity of time to find out a permanent, easy, effective and less side
effect producing care which can be easily administered and accepted by the
patient. The reason we are doing this research is to develop safe, non
invasive, conservative and non hormonal treatment for PCOS.
AIMS & OBJECTIVES:
AIM :-
· To
establish an Ayurvedic standard treatment protocol for management of PCOS.
§ Polycystic ovaries
in USG findings (in unmarried).
§Follicular growth
andovulation (in
married).
SECONDARY OBJECTIVE
To estimate the combined effect of Ayurvedic treatment
protocol on -
â–ª Menstrual irregularities.
â–ª On the recovery of Acne, Hirsutism, Acanthosis
nigricans, BMI, Weight reduction.
â–ª Improvement of quality of the life (PCOS QOL)
EXECUTION OF THE PROPOSED CLINICAL STUDY
STUDY
STUDY TYPE: Non Randomized Clinical Trial
STUDY DESIGN: Interventional study
GROUPING: Single Arm
MASKING: Open Label
TIME: Prospective
STUDY SETTING: The OPD’s and IPD’s of AIIA
SAMPLE POPULATION: Patients from institutional
hospital
CONCEALMENT: Through Registration / UHID NO
SAMPLE SIZE CALCULATION:
ØStudy
aims to see the positive changes based on USG in the patients of PCOS due to
Ayurvedic Treatment Protocol proposed.
ØIt is believed, since Panchakarma procedures are
the part of the protocol, positive developments will definitely occur and it is
assumed that in 80% of the cases positive improvement may occur.
ØAssuming-
Power ofTest as 80%, Level of
Significance as 5% and one-sided test, the calculated sample size is 17.
Assuming 10% dropouts study should include 20 patients.
Ø
INCLUSION
CRITERIA
1.Reproductive Age Group: 16-40 years (both
married/unmarried).
2.Patients with clinical features of PCOS
like-
• Amenorrhea or Oligomenorrhoea
• Infertility
• Anovulation
• Acne
• Hirsutism
• Acanthosis nigricans
3.Along with confirmed any one Polycystic
Ovary in USG finding.
4.Patients fit for Basti and Nasya karma.
5.ICD - 11 Code:5A80.1 Polycystic ovary syndrome
EXCLUSION CRITERIA
1.Primary
amenorrhoea.
2.Pregnancy
3.Pelvic
diseases like (Endometriosis, Hydrosalphinx, Fibroid uterus etc) causing
Oligomenorrhoea and Anovulation.
4.Organic
lesions of reproductive tract like T.B, Carcinoma and congenital deformities.
5.Hyperprolactenemia
due to Pituitary Adenoma.
6.Cushing’s
syndrome
DIAGNOSTIC CRITERIA-
Rotterdam
criteria 2003 (2 out of 3 symptoms if present)
1. Anovulation or Oligo-ovulation .
2. Hyperandrogenism-
a) Clinical -Acne, Hirsutism, Acanthosis Nigricans
b) Biochemical- (elevated S.testosterone ).
3.PCOS
features on USG (12
Follicles of 2- 9mm in size in each ovaryor ovarian volume >10 cc.)
*Blood investigations will be done on 2nd
or 3rd day of menstrual cycle.
Ultrasonography:
·USG-Trans-vaginal
(TVS) in married patients.
·USG-Pelvis in
unmarried patients.
USG protocol
adopted for the study:
1. USG will be
done on 2nd or 3rd day of menses for diagnosis of PCO.
2. USG for
follicular growth, maturity and ovulation will be done on alternate days from
09th to
19th day.
CRITERIA FOR ASSESSMENT
Assessment has done based on both subjective and
objective parameters.
Subjective Parameters:
The improvement in the patient was assessed mainly on
the basis of relief in the signs and symptoms of PCOS like Menstrual pattern
(duration, interval, amount of blood loss), Hirsutism, Acanthosis nigricans, Acne,
BMI, Weight Reduction.